ICH-话题@MedSci

#ICH#

62篇内容 | 2822人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1316353, encodeId=038d131635343, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=Ocaliva（obeticholic acid）：添加黑框警告为突出显示正确的剂量, objectType=article, longId=128825, objectId=9daf12882542, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9daf12882542, replyNumber=0, likeNumber=48, createdTime=2018-02-06, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9daf12882542, moduleTitle=Ocaliva（obeticholic acid）：添加黑框警告为突出显示正确的剂量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9daf12882542)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316352, encodeId=f520131635282, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=JACC：心血管疾病风险评分——FBS vs ICHS评分, objectType=article, longId=120215, objectId=c40b12021520, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c40b12021520, replyNumber=0, likeNumber=81, createdTime=2017-11-17, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c40b12021520, moduleTitle=JACC：心血管疾病风险评分——FBS vs ICHS评分, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c40b12021520)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316351, encodeId=240f131635187, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=[SIBCS2017]在故事开始的地方，Richard S. Finn教授谈CDK4/6抑制剂成功的漫漫长路, objectType=article, longId=117554, objectId=372411e55468, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=372411e55468, replyNumber=0, likeNumber=84, createdTime=2017-10-27, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=372411e55468, moduleTitle=[SIBCS2017]在故事开始的地方，Richard S. Finn教授谈CDK4/6抑制剂成功的漫漫长路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=372411e55468)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316350, encodeId=f80a1316350a3, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=Neurology:Unverricht-Lundborg病病程以及进展因素研究, objectType=article, longId=113617, objectId=743411361e66, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=743411361e66, replyNumber=0, likeNumber=83, createdTime=2017-09-23, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=743411361e66, moduleTitle=Neurology:Unverricht-Lundborg病病程以及进展因素研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=743411361e66)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316349, encodeId=e0621316349f8, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=Blood：基因疗法对Wiskott-Aldrich综合征重度患者的疗效。, objectType=article, longId=105873, objectId=3cbf1058e3bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cbf1058e3bf, replyNumber=0, likeNumber=74, createdTime=2017-07-20, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cbf1058e3bf, moduleTitle=Blood：基因疗法对Wiskott-Aldrich综合征重度患者的疗效。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cbf1058e3bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316348, encodeId=15bd131634816, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=食药监总局：加入ICH可提升制药产业创新能力和国际竞争力, objectType=article, longId=102574, objectId=3e071025e459, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e071025e459, replyNumber=0, likeNumber=51, createdTime=2017-06-21, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e071025e459, moduleTitle=食药监总局：加入ICH可提升制药产业创新能力和国际竞争力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e071025e459)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316347, encodeId=a8f3131634e80, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=CFDA全新简讯：通过申请，成为ICH成员！, objectType=article, longId=102525, objectId=10d110252577, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10d110252577, replyNumber=0, likeNumber=49, createdTime=2017-06-21, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10d110252577, moduleTitle=CFDA全新简讯：通过申请，成为ICH成员！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10d110252577)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316346, encodeId=7e37131634696, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=OrbusNeich推出通过美国食品和药物管理局审批的冠脉扩张导管, objectType=article, longId=101003, objectId=fd7410100318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd7410100318, replyNumber=0, likeNumber=72, createdTime=2017-06-09, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd7410100318, moduleTitle=OrbusNeich推出通过美国食品和药物管理局审批的冠脉扩张导管, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd7410100318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316345, encodeId=8910131634573, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=陈昊：加入ICH后，中国创新医药工业抢先受益, objectType=article, longId=100688, objectId=b1431006887c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1431006887c, replyNumber=0, likeNumber=0, createdTime=2017-06-06, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1431006887c, moduleTitle=陈昊：加入ICH后，中国创新医药工业抢先受益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1431006887c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316344, encodeId=6af413163445a, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=祝贺CFDA！ICH成员国，中国加入正当时！, objectType=article, longId=100532, objectId=c852100532e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c852100532e3, replyNumber=0, likeNumber=66, createdTime=2017-06-04, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c852100532e3, moduleTitle=祝贺CFDA！ICH成员国，中国加入正当时！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c852100532e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316343, encodeId=bf22131634359, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=ICH成员国，中国加入正当时！, objectType=article, longId=100486, objectId=ca541004860d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca541004860d, replyNumber=0, likeNumber=56, createdTime=2017-06-04, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca541004860d, moduleTitle=ICH成员国，中国加入正当时！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca541004860d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316342, encodeId=8068131634248, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=DIA年会速递丨ICH 新的开始：中国希望助力其发展, objectType=article, longId=99353, objectId=a0a299353da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0a299353da, replyNumber=0, likeNumber=0, createdTime=2017-05-24, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0a299353da, moduleTitle=DIA年会速递丨ICH 新的开始：中国希望助力其发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0a299353da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316341, encodeId=09761316341ec, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=Blood：PD-1抗体pembrolizumab治疗慢性淋巴细胞白血病Richter’s转化有效, objectType=article, longId=96976, objectId=a9ad969e617, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9ad969e617, replyNumber=0, likeNumber=59, createdTime=2017-04-26, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9ad969e617, moduleTitle=Blood：PD-1抗体pembrolizumab治疗慢性淋巴细胞白血病Richter’s转化有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9ad969e617)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316340, encodeId=2ce3131634037, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=斯坦福大学医学院Michael Snyder教授谈精准医疗, objectType=article, longId=75975, objectId=2dbce597517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dbce597517, replyNumber=0, likeNumber=50, createdTime=2016-08-28, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dbce597517, moduleTitle=斯坦福大学医学院Michael Snyder教授谈精准医疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dbce597517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316339, encodeId=78ce131633990, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=Stroke: ICH后白细胞升高与血肿扩大减少相关, objectType=article, longId=73615, objectId=00aae361573, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00aae361573, replyNumber=0, likeNumber=75, createdTime=2016-07-26, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00aae361573, moduleTitle=Stroke: ICH后白细胞升高与血肿扩大减少相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00aae361573)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316338, encodeId=55ce13163384a, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=郑心校教授：骨髓干细胞微环境（Niche）与免疫抑制耐受, objectType=article, longId=71319, objectId=dca5e131947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dca5e131947, replyNumber=0, likeNumber=63, createdTime=2016-06-22, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dca5e131947, moduleTitle=郑心校教授：骨髓干细胞微环境（Niche）与免疫抑制耐受, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dca5e131947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316337, encodeId=21ee131633ed2, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=PLoS One：亚洲人群中，女性ICH患者入院时神经功能状态更差, objectType=article, longId=66322, objectId=49c266322aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49c266322aa, replyNumber=0, likeNumber=72, createdTime=2016-04-11, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49c266322aa, moduleTitle=PLoS One：亚洲人群中，女性ICH患者入院时神经功能状态更差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49c266322aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316336, encodeId=dfef131633692, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=Neurology：脑微出血（CMBs）是否与溶栓后症状性颅内出血（ICH）风险增加相关？, objectType=article, longId=56765, objectId=19d056e65b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19d056e65b9, replyNumber=0, likeNumber=73, createdTime=2015-10-01, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19d056e65b9, moduleTitle=Neurology：脑微出血（CMBs）是否与溶栓后症状性颅内出血（ICH）风险增加相关？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19d056e65b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316335, encodeId=2dfc131633505, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=AHA/ASA发布2015自发性ICH指南, objectType=article, longId=51888, objectId=065e51888d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=065e51888d4, replyNumber=0, likeNumber=72, createdTime=2015-06-12, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=065e51888d4, moduleTitle=AHA/ASA发布2015自发性ICH指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=065e51888d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1316334, encodeId=fef2131633435, content=<a href='/topic/show?id=f3789349c3' target=_blank style='color:#2F92EE;'>#ICH#</a>, objectTitle=我国临床试验生物统计学指导原则与国际ICH E9比较研究, objectType=article, longId=38883, objectId=43d6388836b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43d6388836b, replyNumber=0, likeNumber=53, createdTime=2014-08-10, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43d6388836b, moduleTitle=我国临床试验生物统计学指导原则与国际ICH E9比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43d6388836b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ICH

2020-05-29

diushouji (审核中...)

前往app查看评论内容

#ICH#

Ocaliva（obeticholic acid）：添加黑框警告为突出显示正确的剂量

2018-02-06

diushouji (审核中...)

前往app查看评论内容

#ICH#

JACC：心血管疾病风险评分——FBS vs ICHS评分

2017-11-17

diushouji (审核中...)

前往app查看评论内容

#ICH#

[SIBCS2017]在故事开始的地方，Richard S. Finn教授谈CDK4/6抑制剂成功的漫漫长路

2017-10-27

diushouji (审核中...)

前往app查看评论内容

#ICH#

Neurology:Unverricht-Lundborg病病程以及进展因素研究

2017-09-23

diushouji (审核中...)

前往app查看评论内容

#ICH#

Blood：基因疗法对Wiskott-Aldrich综合征重度患者的疗效。

2017-07-20

diushouji (审核中...)

前往app查看评论内容

#ICH#

食药监总局：加入ICH可提升制药产业创新能力和国际竞争力

2017-06-21

diushouji (审核中...)

前往app查看评论内容

#ICH#

CFDA全新简讯：通过申请，成为ICH成员！

2017-06-21

diushouji (审核中...)

前往app查看评论内容

#ICH#

OrbusNeich推出通过美国食品和药物管理局审批的冠脉扩张导管

2017-06-09

diushouji (审核中...)

前往app查看评论内容

#ICH#

陈昊：加入ICH后，中国创新医药工业抢先受益

2017-06-06

diushouji (审核中...)

前往app查看评论内容

#ICH#

祝贺CFDA！ICH成员国，中国加入正当时！

2017-06-04

diushouji (审核中...)

前往app查看评论内容

#ICH#

ICH成员国，中国加入正当时！

2017-06-04

diushouji (审核中...)

前往app查看评论内容

#ICH#

DIA年会速递丨ICH 新的开始：中国希望助力其发展

2017-05-24

diushouji (审核中...)

前往app查看评论内容

#ICH#

Blood：PD-1抗体pembrolizumab治疗慢性淋巴细胞白血病Richter’s转化有效

2017-04-26

diushouji (审核中...)

前往app查看评论内容

#ICH#

斯坦福大学医学院Michael Snyder教授谈精准医疗

2016-08-28

diushouji (审核中...)

前往app查看评论内容

#ICH#

Stroke: ICH后白细胞升高与血肿扩大减少相关

2016-07-26

diushouji (审核中...)

前往app查看评论内容

#ICH#

郑心校教授：骨髓干细胞微环境（Niche）与免疫抑制耐受

2016-06-22

diushouji (审核中...)

前往app查看评论内容

#ICH#

PLoS One：亚洲人群中，女性ICH患者入院时神经功能状态更差

2016-04-11

diushouji (审核中...)

前往app查看评论内容

#ICH#

Neurology：脑微出血（CMBs）是否与溶栓后症状性颅内出血（ICH）风险增加相关？

2015-10-01

diushouji (审核中...)

前往app查看评论内容

#ICH#

AHA/ASA发布2015自发性ICH指南

2015-06-12

diushouji (审核中...)

前往app查看评论内容

#ICH#

我国临床试验生物统计学指导原则与国际ICH E9比较研究

2014-08-10

科室
- - 订阅+
  - 更多科室
工具
服务